International Regulatory Pathways Support Drug Development in Biotech and Pharma
NeOnc Technologies (NASDAQ: NTHI) is leveraging international regulatory pathways, such as the recent Abu Dhabi IND authorization for NEO212. This strategy mirrors broader industry trends seen with companies like Eli Lilly (NYSE: LLY) and Biogen (NASDAQ: BIIB), where global regulatory progress has led to expedited FDA reviews and commercial success.